CSPG4 expression has been identified in several malignancies, including melanoma, glioma, triple-negative breast cancer and pancreatic cancer, as well as in cancer-initiating cells (CICs) [39]. This evidence concerns the gene CSPG4 and triple-negative breast carcinoma.